Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance

Oncogene

Volumn 26, Issue 14, 2007, Pages 2027-2038

  Kilic, M ^a   Kasperczyk, H ^a   Fulda, S ^a   Debatin, K M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Ewing sarcoma; Hif 1 ; Hypoxia; Rhabdomyosarcoma

Indexed keywords

E1B PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN BCL 2; PROTEIN P53;

ANAEROBIC METABOLISM; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EWING SARCOMA; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHABDOMYOSARCOMA; RNA INTERFERENCE; STATISTICAL SIGNIFICANCE;

ANOXIA; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INHIBITOR OF APOPTOSIS PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING;

EID: 34047105144     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210008     Document Type: Article

References (48)

1. Akakura N, Kobayashi M, Horiuchi I, Suzuki A, Wang J, Chen J et al. (2001). Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61: 6548-6554.
2. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, Carrera AC, Landazuri MO, Del Peso L. (2001). Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 276: 22368-22374.
3. An GW, Kanekal Meera, Simon MC, Maltepe E, Blagosklonny MV, Neckers ML. (1998). Stabilization of wild-type p53by hypoxia-inducible factor 1alpha. Nature 392: 405-408.
4. Blum R, Hirsch J-J, Amariglio N, Rechavi G, Kloog Y. (2005). Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res 65: 3999.
5. Bruick RK. (2000). Expression of the gene encoding the proapoptotic Nip3protein is induced by hypoxia. Proc Natl Acad Sci 97: 9082-9087.
6. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490.
7. Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F et al. (2003). Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathal 162: 1283-1291.
8. Dagher R, Hellman L. (1999). Rhabdomyosarcoma: an overview. Oncologist 4: 34-44.
9. Discher DJ, Bishopric NH, Wu X, Peterson CA, Webster KA. (1998). Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem 273: 26087-26093.
10. Dong Z, Wang JZ, Yu F, Venkatachalam MA. (2003). Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2. Am J Pathol 163: 663-671.
11. Erler JT, Cawthorne CJ, Williams KJ, Koritzinsky M, Wouters BG, Wilson C et al. (2004). Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol, 2875-2879.
12. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57: 3823-3829.
13. Ganjavi H, Gee M, Narendran A, Freedman HM, Malkin D. (2005). Adenovirus-mediated p53gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther 12: 397-406.
14. Gatenby RA, Gillies RJ. (2004). Why do cancers have high aerobic glycolysis? Nat Rev Cancer 11: 891-899.
15. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K et al. (2001). Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8: 367-376.
16. Harris AL. (2002). Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
17. Hochachka PW, Lutz PL. (2001). Mechanism, origin, and evolution of anoxia tolerance in animals. Comp Biochem Physiol 130B: 435-459.
18. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH et al. (2002). Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111: 709-720.
19. Kan O, Baldwin SA, Whetton AD. (1994). Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line. J Exp Med 180: 917-923.
20. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. (2004a). BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med, 113-123.
21. Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW. (2004b). Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res 64: 4078-4081.
22. Lin Z, Weinberg JM, Malhotra R, Merritt SE, Holzman LB, Brosius III FC. (2000). GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am J of Physiol Endocrinol Metab 278: 958-966.
23. Mackall CL, Meltzer PS, Helman LJ. (2002). Focus on sarcomas. Cancer Cell 2: 175-178.
24. Mahon PC, Hirota K, Semenza GL. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686.
25. Mathupala SP, Rempel A, Pedersen PL. (2001). Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 276: 43407-43412.
26. Merrall NW, Plevin R, Gould GW. (1993). Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal 5: 667-675.
27. Mukopadhyay CK, Mazumder B, Fox PL. (2000). Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275: 21048-21054.
28. Murphy BJ, Andrews GK, Bittel D, Discher DJ, McCue J, Green CJ et al. (1999). Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res 59: 1315-1322.
29. Ormerod MG. (1992). Flow Cytometry A Practical Approach. Oxford University Press Inc.: New York, NY.
30. Pappo AS, Shapiro DN, Christ WM. (1997). Rhabdomyosarcoma. Biology and treatment. Pediatr Clin N Am 44: 953-972.
31. Park SY, Billar TR, Seol DW. (2002). Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Biophys Res Commun 291: 150-153.
32. Piret JP, Lecocq C, Toffoli S, Ninane N, Raes M, Michiels C. (2004). Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp Cell Res 295: 340-349.
33. Plas DR, Thompson CB. (2002). Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 13: 74-78.
34. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC et al. (2000). BNIP3heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275: 1439-1448.
35. Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ. (2005). Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7: 324-330.
36. Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T. (2005). Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96: 394-402.
37. Schreiber E, Matthias P, Muller MM, Schaffner W. (1989). A rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 17: 6419.
38. Semenza GL. (2000). HIF-1: using two hands to flip the angiogenic switch. Cancer Metast Rev 19: 59-65.
39. Semenza GL. (2001). HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1-3.
40. Semenza GL. (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
41. Semenza GL, Agani F, Feldser D. (2000). Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 475: 123-130.
42. Semenza GL, Roth PH, Fang HM, Wang GL. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763.
43. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. (2001). Cancer Res 61: 6669-6673.
44. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. (2003). HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 63: 6130-6142.
45. Webster KA, Discher DJ, Hernandez OM, Yamashita K, Bishopric NH. (2000). A glycolytic pathway to apoptosis of hypoxic cardiac myocytes. Molecular pathways of increased acid production. Adv Exp Med Biol 475: 161-175.
46. West DC. (2000). Ewing sarcoma family of tumors. Curr Opin Oncol 12: 323-329.
47. Zhang Q, Zhang ZF, Rao JY, Sato JD, Brown J, Messadi DV et al. (2004). Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas. Int J Cancer 111: 849-857.
48. Zhong H, De Marzo AM, Laughner E, Lim M. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastase. Cancer Res 59: 5830-5835.